显示标签为“wharton-school”的博文。显示所有博文
显示标签为“wharton-school”的博文。显示所有博文

2012年1月27日星期五

Remembering William Polk Carey: A Legendary Black Swan Investor

Source: Dudley Reed Photography Source: Dudley Reed Photography
The oldest known reference to a “black swan” comes from the poet Juvenal’s characterization (in Latin) of something being “rara avis in terris nigroque simillima cygno,” or as translated in English means “a rare bird in the lands, and very like a black swan.”
When this early phrase was coined, the black swan was presumed not to exist and it was more of a legendary bird with attributes identifiable by excellence and superior intelligence.
In addition to the black swan’s rare plumage, the unique bird was portrayed as a visionary leader with extraordinary intellect.
Wm. Polk Carey was also a rare entrepreneur, leader and investor. Beginning from his birth in 1930 (during the depression), Carey spent his childhood determined to make a difference in the world.
His passion and vision were the foundational straws for a global investment operation–W.P. Carey & Co., LLC–that has survived more than four decades of prosperity and success. As a descendant of James F. Polk (the 11th President of the United States), Carey’s insightful investment perspectives were far-reaching as the “black swan” was a visionary leader in the essence of risk-control and his sound risk-management strategies were evolutionary.
After graduating from the Wharton School (in 1953) with a degree in economics, Carey held senior positions in prominent investment firms. He then focused his defensive investment career on providing consistent and durable income products differentiated by sound, risk-aligned fundamentals. In 1973, he started W.P. Carey & Co. and his real estate model, built on risk-avoidance principles, became the pioneer and leader in sale-leaseback investing.
One of the “black swan’s” strongest sources of differentiation is also one of the company’s principle objectives –“Investing for the Long Run ™ ”–for Carey spent his entire life, staring from his earliest childhood days, striving to be a leader and teacher of honesty, humility and loyalty. That dedication to purpose has been the wind behind the “black swan” and the company’s highly sustainable model rooted by integrity and skillful risk control–the mark of a superior investor.
Carey’s investment philosophy, “Investing for the Long Run ™” became a fitting measure for shareholder and investor performance as the company’s strategy of financing the growth of worthy companies became a beacon for other “black swans” to follow.  As Howard Marks, author of The Most Important Thing wrote, “Successful investing is about managing risk, not avoiding it.” Carey was perhaps one of the leaders in managing investor risk and his innovative risk-aligned real estate products have grown to global proportions.
Today W.P. Carey is the leading global net-lease investor with assets of just under $12 billion in 18 countries across 28 different industries. As Carey once said, “we (W.P. Carey) are unique. No other company has the same business mix or approach.”
As a global triple-net lease investor, W.P. Carey built its sound sale-leaseback platform on broad diversification fundamentals. Some of the strategically risk-aligned tenants include Sun Products ($41 million), Tesco ($90 million), The New York Times (NYT) ($225 million), Dick’s Sporting Goods (DKS) ($18.5 million), and Hellweg Die Profi-Baumärkte (the company’s largest transaction to date at $446 million).
And this “black swan” approach has provided for some exceptional performance as the company has increased its dividend every year since it went public in 1998 and for the most recent 43 consecutive quarters. Since the introduction of the first investment program in 1979, W.P. Carey and its affiliates have paid more than $3.8 billion to investors over 640 consecutive quarterly cash distributions.
http://tourism9.com/    http://vkins.com/

2012年1月4日星期三

Morgan Joseph TriArtisan Adds Two Managing Directors to Its Healthcare Investment Banking Group

NEW YORK–(BUSINESS WIRE)– Morgan Joseph TriArtisan LLC, the investment and merchant bank focused on middle market companies, today announced the addition of two new Managing Directors, John Cramer and Andy Sherman, to its Healthcare Investment Banking Group, reporting to Group Head Marc Cabrera.
Mr. Cramer, has over 15 years of experience working with companies in the Specialty Pharmaceuticals, Healthcare IT and Healthcare Services subsectors, including completed engagements for equity and debt financing, M&A and restructuring. Since 1996 he has completed over 115 transactions having an aggregate value in excess of $20 billion.
Mr. Sherman has over 17 years of M&A expertise with a focus on Healthcare Services, Specialty Pharmaceuticals and Medical Devices. He has completed over 90 transactions with an aggregate value in excess of $35 billion.
“The addition of John and Andy to our existing team bolsters our already strong presence in healthcare and underscores our firm’s commitment to continued growth,” said Mary Lou Malanoski, Morgan Joseph TriArtisan’s Vice Chair and Head of Investment Banking. “Their industry expertise, extensive relationships and diverse skills are a complement to our firm’s focus on providing differentiated, high-value services to the middle market. We believe Morgan Joseph TriArtisan is increasingly well positioned to serve this market with a solid core of professionals, and we are delighted to have John and Andy join our firm.
“Current conditions in the securities business provide us with the opportunity to add exceptionally qualified investment bankers like John and Andy, at a time when many of our competitors are reducing their staffs. Morgan Joseph TriArtisan is committed to continue building capabilities in our four core industry verticals in order to better serve our investment banking clients.”
Previously, Mr. Cramer spent nine years at Gleacher & Company covering Healthcare, where he successfully completed lead-managed initial public offerings and follow-on equity offerings, private placements of debt and equity, buy-side and sell-side M&A transactions and creditor and debtor-side restructurings. Earlier, he covered Healthcare IT and services at Robertson, Stephens & Company and was an associate at Dewey Ballantine LLP in New York City. He holds a Juris Doctor from The University of Michigan Law School and a BA from Albion College and Oxford University.
Prior to joining Morgan Joseph TriArtisan, Mr. Sherman was a senior member of the Healthcare Investment Banking Group at Madison Williams. From 2007 to 2009, Mr. Sherman worked in principal investing for KBL Healthcare Acquisition Corp. and Capitol Acquisition Corp., sourcing and executing transactions across various industries including healthcare services, specialty pharmaceuticals, and medical devices. From 2001 to 2007, Mr. Sherman was at Banc of America Securities where he was a Principal in Investment Banking. Earlier, Mr. Sherman worked at Montgomery Securities and James D. Wolfensohn, Inc. Mr. Sherman received a Masters of Business Administration with Distinction from Harvard Business School, a B.S. in Economics from the Wharton School of Business and a B.A. in International Relations from the University of Pennsylvania.
About Morgan Joseph TriArtisan LLC
Morgan Joseph TriArtisan LLC (www.mjta.com) is an investment and merchant bank engaged in providing financial advice, capital raising and private equity investing. The firm’s services include mergers, acquisitions and restructuring advice, in addition to private placements and public offerings of equity and debt, as well as research for institutional clients
http://tourism9.com/